The Faster Path to Self-Administration: Moving from Pre-Filled Syringe to Auto-Injector
Summary: As a pharma company looks to make the transition from a traditional pre-filled syringe (PFS) to an auto-injector, both its device partner and its manufacturing partner must bring their own set of expertise to the 3-way partnership. It’s imperative that the three teams work together to meet product, device, quality, manufacturing, and packaging requirements. When experienced partners understand lifecycle management and anticipate equipment and process needs, the product can be transitioned from PFS to auto-injector more quickly. Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar.